A carregar...

Head and Neck Cancer Immunotherapy beyond the Checkpoint Blockade

The success of immune checkpoint receptor blockade has brought exciting promises for the treatment of head and neck squamous cell carcinoma (HNSCC). While patients who respond to checkpoint inhibitors tend to develop a durable response, <15% of patients with HNSCC respond to immune checkpoint inh...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Dent Res
Main Authors: Heath, B.R., Michmerhuizen, N.L., Donnelly, C.R., Sansanaphongpricha, K., Sun, D., Brenner, J.C., Lei, Y.L.
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6704427/
https://ncbi.nlm.nih.gov/pubmed/31340724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0022034519864112
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!